RSS Feeds
Search

In-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

No results found for given criteria.
Please try to put more general criteria into your selection.

Related Reports

Market Research Reports provided by reports.iptechex.com
Gaucher's Disease Therapy Area Pipeline Report
Nov 2010 - 83 pages - $1,495
Gaucher Disease Type 1 - Pipeline Review, Q4 2010
Nov 2010 - 50 pages - $500
Personalized Medicine
Aug 2007 - 87 pages - $1,999
Gaucher's Disease Global Clinical Trials Review, Q2, 2011
Jun 2011 - 44 pages - $1,000
Personalized Medicine Partnering Terms and Agreements
Apr 2011 - 951 pages - $4,995
Gaucher's Disease - Pipeline Review, Q2 2011
May 2011 - 64 pages - $500
Delay in Phase-out Plan Will Benefit the German Nuclear Industry
Oct 2009 - 13 pages - $500
Hot Topics: Impact of Biomarkers in Alzheimer's Disease - Dx-Rx collaboration paves the way for personalized medicine
Dec 2011 - 50 pages - $3,800
Protalix BioTherapeutics, Inc. - Product Pipeline Review - Q4 2010
Dec 2010 - 39 pages - $500
Gentium S.p.A’s Defibrotide Set to Become the First Treatment Option for Veno-occlusive Disease (VOD)
Jul 2011 - 5 pages - $500
More Related Market Research Reports >>>

Your selection

Industry sector
Diagnostic del
Nuclear medicine del
Therapeutic target
Metabolism del
Gaucher's disease del
Development phase
Phase III/IV del

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us